We are live on
!
Find out more
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
4 hedge funds and large institutions have $2.07K invested in Sienna Biopharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% less funds holding
Funds holding: 23 → 4 (-19)
95% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 20
100% less capital invested
Capital invested by funds: $1.08M → $2.07K (-$1.08M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
4
Holders Change
-19
Holders Change %
-82.61%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PO
Private Ocean
San Rafael,
California
|
+$102 |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$920K |
| 2 |
GSWM
Golden State Wealth Management
Santa Ana,
California
|
-$36K |
| 3 |
Millennium Management
New York
|
-$24K |
| 4 |
BlackRock
New York
|
-$18K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$17K |
